Plain-English translation of NCT05583773 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a traditional Chinese herbal formula called in people with heart failure. Researchers want to see whether this medication, given twice daily alongside your regular heart failure treatment, can improve how you feel, reduce your symptoms, and help your heart function better. Half of participants will receive the active medication, and half will receive a placebo (a look-alike with no active ingredients) so researchers can measure the true effects.
Heart failure is a serious condition that affects millions of people worldwide, and many patients still struggle with symptoms and limitations even on standard treatments. This trial explores whether this traditional medicine approach might offer additional benefit to people whose hearts are not pumping well enough.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either the or a matching placebo, both taken twice daily in addition to your regular heart failure medications. The study involves visits at hospitals across China where researchers will check your symptoms, quality of life, heart function through blood tests and imaging, and track how you feel over time. You would continue your standard heart failure care with your regular doctor while participating in this study.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
China